Skip to main content
Clinical Trials/IRCT20210926052602N1
IRCT20210926052602N1
Recruiting
Phase 3

Comparison of the effect of Metformin and Empagliflozin in treatment of prediabetic patients.

Kashan University of Medical Sciences0 sites100 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Prediabetes.
Sponsor
Kashan University of Medical Sciences
Enrollment
100
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Prediabetic patient
  • Age between 30\-80 years old

Exclusion Criteria

  • Treatment with hormones or drugs that interference glucose metabolism
  • Neurogenic bladder disorder
  • Pregnant or breast feeding mothers
  • Allergy to Empagliflozin or Metformin

Outcomes

Primary Outcomes

Not specified

Similar Trials